Education
About Us
Working with TipRanks
Follow Us
Calidi Biotherapeutics (CLDI)
:CLDI
See the Price Targets and Ratings of:
CLDI Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Robert W. Baird
$2.5
Buy
331.03%
Upside
Reiterated
11/17/24
Calidi Biotherapeutics: Innovative Cancer Treatment with Promising Clinical Results but Financial Challenges
Ladenburg Thalmann & Co.
$10
Buy
1624.14%
Upside
Initiated
06/27/24
Calidi initiated with a Buy at LadenburgCalidi initiated with a Buy at Ladenburg
Unknown Analyst
Not Ranked
Rodman & Renshaw
$10
Buy
1624.14%
Upside
Initiated
06/27/24
Rodman Renshaw starts Calidi Biotherapeutics Inc (CLDI) at BuyRodman Renshaw initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI) with a Buy rating and a price target of $1.00.
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Robert W. Baird
$2.5
Buy
331.03%
Upside
Reiterated
11/17/24
Calidi Biotherapeutics: Innovative Cancer Treatment with Promising Clinical Results but Financial Challenges
Ladenburg Thalmann & Co.
$10
Buy
1624.14%
Upside
Initiated
06/27/24
Calidi initiated with a Buy at LadenburgCalidi initiated with a Buy at Ladenburg
Unknown Analyst
Not Ranked
Rodman & Renshaw
$10
Buy
1624.14%
Upside
Initiated
06/27/24
Rodman Renshaw starts Calidi Biotherapeutics Inc (CLDI) at BuyRodman Renshaw initiates coverage on Calidi Biotherapeutics Inc (NYSE: CLDI) with a Buy rating and a price target of $1.00.
CLDI Analyst Recommendation Trends
Rating
Nov 23
Mar 24
May 24
Jun 24
Sep 24
Strong Buy
3
5
5
5
3
Buy
0
0
0
0
0
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
5
5
5
4
Each month's total comprises the sum of three months' worth of ratings.
CLDI Stock Forecast FAQ
What is CLDI’s average 12-month price target, according to analysts?
Based on analyst ratings, Calidi Biotherapeutics’s 12-month average price target is $2.50.
What is CLDI’s upside potential, based on the analysts’ average price target?
Calidi Biotherapeutics has 331.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CLDI a Buy, Sell or Hold?
Calidi Biotherapeutics has a consensus rating of Moderate Buy which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Calidi Biotherapeutics’s price target?
The average price target for Calidi Biotherapeutics is $2.50. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $2.50 ,the lowest forecast is $2.50. The average price target represents 331.03% Increase from the current price of $0.58.
The highest analyst price target is $2.50 ,the lowest forecast is $2.50. The average price target represents 331.03% Increase from the current price of $0.58.
What do analysts say about Calidi Biotherapeutics?
Calidi Biotherapeutics’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of CLDI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.